Literature DB >> 14501110

Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution.

Sanjeev Munshi1, Dawn L Hall, Maria Kornienko, Paul L Darke, Lawrence C Kuo.   

Abstract

The crystal structure of the wild-type unactivated kinase domain (IGFRK-0P) of insulin-like growth factor-1 receptor has been reported previously at 2.7 A resolution [Munshi et al. (2002), J. Biol. Chem. 277, 38797-38802]. In order to obtain a high-resolution structure, a number of variants of IGFRK-0P were prepared and screened for crystallization. A double mutant with E1067A and E1069A substitutions within the kinase-insert region resulted in crystals that diffracted to 1.5 A resolution. Overall, the structure of the mutant IGFRK-0P is similar to that of the wild-type IGFRK-0P structure, with the exception of the previously disordered kinase-insert region in the wild type having become fixed. In addition, amino-acid residues 947-952 at the N-terminus are well defined in the mutant structure. The monomeric protein structure is folded into two lobes connected by a hinge region, with the catalytic center situated at the interface of the two lobes. Two molecules of IGFRK-0P in the asymmetric unit are associated as a dimer and two different types of dimers with their ATP-binding clefts either facing towards or away from each other are observed. The current refined model consists of a dimer and 635 water molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501110     DOI: 10.1107/s0907444903015415

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  33 in total

1.  Harvesting the high-hanging fruit: the structure of the YdeN gene product from Bacillus subtilis at 1.8 angstroms resolution.

Authors:  Izabela Janda; Yancho Devedjiev; David Cooper; Maksymilian Chruszcz; Urszula Derewenda; Aleksandra Gabrys; Wladek Minor; Andrzej Joachimiak; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-05-21

2.  The crystal structure of the reduced, Zn2+-bound form of the B. subtilis Hsp33 chaperone and its implications for the activation mechanism.

Authors:  Izabela Janda; Yancho Devedjiev; Urszula Derewenda; Zbigniew Dauter; Jakub Bielnicki; David R Cooper; Paul C F Graf; Andrzej Joachimiak; Ursula Jakob; Zygmunt S Derewenda
Journal:  Structure       Date:  2004-10       Impact factor: 5.006

3.  Application of protein engineering to enhance crystallizability and improve crystal properties.

Authors:  Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-04-21

4.  Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).

Authors:  William Engen; Terrence E O'Brien; Brendan Kelly; Jacinda Do; Liezel Rillera; Lance K Stapleton; Jack F Youngren; Marc O Anderson
Journal:  Bioorg Med Chem       Date:  2010-06-25       Impact factor: 3.641

5.  Trading the micro-world of combinatorial complexity for the macro-world of protein interaction domains.

Authors:  Nikolay M Borisov; Nick I Markevich; Jan B Hoek; Boris N Kholodenko
Journal:  Biosystems       Date:  2005-10-19       Impact factor: 1.973

6.  Atomic-resolution crystal structure of Borrelia burgdorferi outer surface protein A via surface engineering.

Authors:  Koki Makabe; Valentina Tereshko; Grzegorz Gawlak; Shude Yan; Shohei Koide
Journal:  Protein Sci       Date:  2006-07-05       Impact factor: 6.725

7.  Autoinhibition of the insulin-like growth factor I receptor by the juxtamembrane region.

Authors:  Barbara P Craddock; Christopher Cotter; W Todd Miller
Journal:  FEBS Lett       Date:  2007-06-19       Impact factor: 4.124

8.  Toward rational protein crystallization: A Web server for the design of crystallizable protein variants.

Authors:  Lukasz Goldschmidt; David R Cooper; Zygmunt S Derewenda; David Eisenberg
Journal:  Protein Sci       Date:  2007-08       Impact factor: 6.725

Review 9.  Targeting insulin-like growth factor type 1 receptor in cancer therapy.

Authors:  Francesco Atzori; Tiffany A Traina; Maria Teresa Ionta; Bruno Massidda
Journal:  Target Oncol       Date:  2009-10-30       Impact factor: 4.493

10.  Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Authors:  Jinhua Wu; Wanqing Li; Barbara P Craddock; Kenneth W Foreman; Mark J Mulvihill; Qun-sheng Ji; W Todd Miller; Stevan R Hubbard
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.